The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease
about
The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical OverviewThe Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseTransplantation of Donor-Origin Mouse Embryonic Stem Cell-Derived Thymic Epithelial Progenitors Prevents the Development of Chronic Graft-versus-Host Disease in Mice.Vitamin D Modulation of TRAIL Expression in Human Milk and Mammary Epithelial Cells.Administration of anti-CD20 mAb is highly effective in preventing but ineffective in treating chronic graft-versus-host disease while preserving strong graft-versus-leukemia effectsRepertoire enhancement with adoptively transferred female lymphocytes controls the growth of pre-implanted murine prostate cancer.Impaired thymic expression of tissue-restricted antigens licenses the de novo generation of autoreactive CD4+ T cells in acute GVHD.Rabbit antithymocyte globulin (thymoglobulin) impairs the thymic output of both conventional and regulatory CD4+ T cells after allogeneic hematopoietic stem cell transplantation in adult patients.Blockade of individual Notch ligands and receptors controls graft-versus-host diseaseThymus: the next (re)generation.Antibodies are back for thymic attack in cGVHD.Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice.Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activityThymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells.Utilization of TREC and KREC quantification for the monitoring of early T- and B-cell neogenesis in adult patients after allogeneic hematopoietic stem cell transplantation.The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host diseaseThymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again.Medullary thymic epithelial stem cells: role in thymic epithelial cell maintenance and thymic involution.Poor antibody validation is a challenge in biomedical research: a case study for detection of c-FLIP.CD4+ T cell-depleted lymphocyte infusion impairs neither the recovery of recipient thymus nor the development of transplanted thymus.Comparison of different rabbit ATG preparation effects on early lymphocyte subset recovery after allogeneic HSCT and its association with EBV-mediated PTLD.PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells.Extrafollicular CD4+ T-B interactions are sufficient for inducing autoimmune-like chronic graft-versus-host disease.Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells.Memory lapses in graft-versus-host disease.Loss of thymic innate lymphoid cells leads to impaired thymopoiesis in experimental graft-versus-host disease.Long-Lasting Graft-Derived Donor T Cells Contribute to the Pathogenesis of Chronic Graft-versus-Host Disease in Mice.A preclinical acute GVHD mouse model based on chemotherapy conditioning and MHC-matched transplantation.Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: a multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
P2860
Q28066083-FA5D304C-322C-4958-A2FC-7775437C35A8Q28076264-C2AA5E47-33A0-44F9-AFD8-EC63EFDBBE73Q33722135-6B6EBE24-A69B-4B1F-AA51-DF7FF419EE7CQ33849195-3512DE75-3D45-48E1-9A3A-8E70102A31AFQ33905411-E7CC8DA2-3F07-48F4-A994-A4A66B42572FQ34228613-127BE3F6-8873-4F9C-A08B-425FA8804727Q35561300-467FFE09-AC01-4357-A730-0CEAB453AA92Q36498340-D870C414-48B6-4E62-97A3-860B66DFC307Q36733439-9CCF074D-54B2-4D3F-AB98-D181B696B60CQ36815662-E65AA858-511F-44AF-8173-02F26AEECF53Q36876960-3F8FAC1D-81DC-4B26-A701-1FA50ED0E684Q36876981-6A5E02DE-204C-4B9E-B6DB-BEC9BE4A6070Q36891101-F4622230-AFEB-4502-B548-BF65539A3C96Q37104254-8B3F8D68-E267-4C38-AC0B-62BA85B53958Q37115326-6A58C982-712B-4131-AB2B-CCCC3DBB7FC5Q37390250-A68BD89B-C75A-4799-986F-B03B1E79CEABQ37973391-A3B0E2E4-FF92-493E-B2B9-08627A616597Q38810883-60E9B031-0477-4E9F-ADDD-31D09912817DQ39114961-D849DCBF-D6DA-4BCF-B30E-4F5C9DC56830Q42117471-BC63D070-A89B-4AB4-A833-970CAF845A11Q42210284-367E30DD-D04A-4986-A41D-872B63DE6F14Q42256164-58B2429E-EE1F-471C-87C3-85822451F680Q42379668-96631AFC-6F7C-461D-9950-05A230427F56Q42453294-A2612B88-E3B6-4A00-9923-2798A2750314Q43443166-9D2BB3AD-64BE-4478-B597-F14CFD81A976Q48290042-3A2EAAEC-C601-44CF-8A97-C9DF5B4F3900Q49226116-1E75163B-5C83-46DB-BB1F-76B5F9A9562BQ52860217-BAA54180-D467-4217-8184-919C04218ED9Q56576062-F2833ABB-D3C6-4960-8FB5-C408FE6674D0
P2860
The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The cytolytic molecules Fas li ...... ymic graft-versus-host disease
@ast
The cytolytic molecules Fas li ...... ymic graft-versus-host disease
@en
The cytolytic molecules Fas li ...... mic graft-versus-host disease.
@nl
type
label
The cytolytic molecules Fas li ...... ymic graft-versus-host disease
@ast
The cytolytic molecules Fas li ...... ymic graft-versus-host disease
@en
The cytolytic molecules Fas li ...... mic graft-versus-host disease.
@nl
prefLabel
The cytolytic molecules Fas li ...... ymic graft-versus-host disease
@ast
The cytolytic molecules Fas li ...... ymic graft-versus-host disease
@en
The cytolytic molecules Fas li ...... mic graft-versus-host disease.
@nl
P2093
P2860
P50
P356
P1476
The cytolytic molecules Fas li ...... ymic graft-versus-host disease
@en
P2093
Amanda M Holland
Christopher G King
Daniel Hirschhorn-Cymerman
Gabrielle L Goldberg
Il-Kang Na
Jennifer Tsai
Lia Palomba
P2860
P304
P356
10.1172/JCI39395
P407
P577
2009-12-01T00:00:00Z